Personal review: is profound acid inhibition safe?
Open Access
- 1 January 2000
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (1) , 15-22
- https://doi.org/10.1046/j.1365-2036.2000.00681.x
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Heartburn without Oesophagitis: Efficacy of Omeprazole Therapy and Features Determining Therapeutic ResponseScandinavian Journal of Gastroenterology, 1997
- Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and SafetyAnnals of Internal Medicine, 1994
- H2 antagonist and omeprazole nonrespondersDigestive Diseases and Sciences, 1991
- Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidineGastroenterology, 1990
- Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade.Gut, 1986
- Enterochromaffin-Like Cell Carcinoids of Gastric Mucosa in Rats after Life-Long Inhibition of Gastric SecretionDigestion, 1986
- Texicological studies on omeprazoleScandinavian Journal of Gastroenterology, 1985
- Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.Gut, 1984
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981
- Definition and Antagonism of Histamine H2-receptorsNature, 1972